Literature DB >> 7430367

Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

M W Kenny, A J George, J Stuart.   

Abstract

Platelet function was measured on 29 occasions in 16 adult patients in the asymptomatic steady state of sickle-cell anaemia. There was a significant increase in platelet number and micro-aggregate formation, and a lower aggregation threshold with adenosine diphosphate, compared with 23 healthy controls. Similar changes were found, however, in 12 splenectomised patients without sickle-cell diseases. The platelet hyperactivity of the sickle-cell steady state therefore reflects an increased circulating population of young, metabolically active platelets resulting from previous autosplenectomy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430367      PMCID: PMC1146172          DOI: 10.1136/jcp.33.7.622

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  27 in total

1.  Hetrogeneity of human platelets. 3. Glycogen metabolism in platelets of different sizes.

Authors:  S Karpatkin; A Charmatz
Journal:  Br J Haematol       Date:  1970-08       Impact factor: 6.998

2.  Impaired fibrinolysis in sickle cell disease. Relation to crisis and infection.

Authors:  D Green; G Kwaan HC RUIZ
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31

3.  The liver in sickle cell anemia. A clinical-pathologic study.

Authors:  H J Rosenblate; R Eisenstein; A W Holmes
Journal:  Arch Pathol       Date:  1970-09

4.  Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.

Authors:  R H Aster
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  Evidence that the spleen retains the youngest and hemostatically most effective platelets.

Authors:  N R Shulman; S P Watkins; S B Itscoitz; A B Students
Journal:  Trans Assoc Am Physicians       Date:  1968

6.  Functional asplenia in sickle-cell anemia.

Authors:  H A Pearson; R P Spencer; E A Cornelius
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

7.  Platelet volume and shape in relation to aggregation and adhesion.

Authors:  P M Mannucci; A A Sharp
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

8.  Platelet function tests in thrombocythaemia and thrombocytosis.

Authors:  P D McClure; G I Ingram; R S Stacey; U H Glass; M O Matchett
Journal:  Br J Haematol       Date:  1966-07       Impact factor: 6.998

9.  Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

10.  Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  23 in total

Review 1.  Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.

Authors:  Rakhi P Naik; Michael B Streiff; Sophie Lanzkron
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

Review 2.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

3.  Mechanisms of hemolysis-associated platelet activation.

Authors:  C C Helms; M Marvel; W Zhao; M Stahle; R Vest; G J Kato; J S Lee; G Christ; M T Gladwin; R R Hantgan; D B Kim-Shapiro
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

Review 4.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

5.  Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Authors:  Rakhi P Naik; Michael B Streiff; Carlton Haywood; Julie A Nelson; Sophie Lanzkron
Journal:  Am J Med       Date:  2013-05       Impact factor: 4.965

6.  Haematological stress syndrome in atherosclerosis.

Authors:  J Stuart; A J George; A J Davies; A Aukland; R A Hurlow
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

7.  Development of impaired splenic function in intestinal lymphangiectasia.

Authors:  P N Foster; A W Bullen; D A Robertson; D M Chalmers; M S Losowsky
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

Review 8.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

Review 9.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

10.  Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.

Authors:  José Villagra; Sruti Shiva; Lori A Hunter; Roberto F Machado; Mark T Gladwin; Gregory J Kato
Journal:  Blood       Date:  2007-05-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.